non-small cell lung cancer
PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC
In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.
A Spanish team is hoping it can further validate promising early results using TCR characteristics to predict the success or failure of pre-surgery chemoimmunotherapy.
FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC
This is the first time the FDA has approved a drug specifically for NSCLC patients who harbor rare EGFR Exon20 insertion mutations.
Japanese Health Ministry Clears Thermo Fisher Scientific Oncomine Assay as CDx for Lung Cancer Drug
The Oncomine Dx Target Test can now be used to identify patients with RET-fusion positive NSCLC who may be treated with Eli Lilly's selpercatinib.
Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment.